Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Hallador Energy
HNRG
$764M
| $6.67M | 0.01% |
667,155
-51,500
| -7% | -$424K |
|
1327
Gaotu Techedu
GOTU
$401M
| $6.66M | 0.01% |
2,819,900
-1,759,789
| -38% | -$2.54M |
|
|
SGMO
1328
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $6.66M | 0.01% |
2,119,496
+453,400
| +27% | +$1.76M |
|
1329
Helix Energy Solutions
HLX
$1.54B
| $6.63M | 0.01% |
897,826
+249,994
| +39% | +$1.5M |
|
1330
CareTrust REIT
CTRE
$9.22B
| $6.62M | 0.01% |
356,300
+168,500
| +90% | +$3.15M |
|
|
OLPX
1331
DELISTED
Olaplex Holdings
OLPX
| $6.62M | 0.01% |
1,270,700
+907,800
| +250% | +$5.39M |
|
1332
Simmons First National
SFNC
$3.46B
| $6.61M | 0.01% |
+306,257
| New | +$6.96M |
|
1333
Center Bancorp
CNOB
$1.79B
| $6.6M | 0.01% |
272,687
-33,502
| -11% | -$823K |
|
1334
DoubleVerify
DV
$2.04B
| $6.59M | 0.01% |
300,300
+64,100
| +27% | +$1.67M |
|
1335
Coca-Cola Europacific Partners
CCEP
$47.4B
| $6.59M | 0.01% |
119,100
+60,900
| +105% | +$3.06M |
|
1336
Amylyx Pharmaceuticals
AMLX
$2.42B
| $6.59M | 0.01% |
+178,300
| New | +$6.33M |
|
1337
MillerKnoll
MLKN
$1.62B
| $6.59M | 0.01% |
313,583
-242,100
| -44% | -$4.85M |
|
1338
Endava
DAVA
$165M
| $6.58M | 0.01% |
+86,000
| New | +$6.4M |
|
1339
Gartner
IT
$11.3B
| $6.55M | 0.01% |
19,500
-44,300
| -69% | -$14.3M |
|
1340
Ryan Specialty Holdings
RYAN
$10.8B
| $6.55M | 0.01% |
157,900
-134,000
| -46% | -$5.48M |
|
1341
Lakeland Industries
LAKE
$119M
| $6.55M | 0.01% |
492,302
-34,200
| -6% | -$433K |
|
1342
Gran Tierra Energy
GTE
$334M
| $6.54M | 0.01% |
660,560
-11,718
| -2% | -$138K |
|
1343
Conduent
CNDT
$241M
| $6.54M | 0.01% |
1,614,200
-145,400
| -8% | -$557K |
|
1344
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $6.5M | 0.01% |
+204,080
| New | +$6.45M |
|
1345
Ethan Allen Interiors
ETD
$578M
| $6.47M | 0.01% |
244,800
+140,200
| +134% | +$3.62M |
|
1346
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.45M | 0.01% |
165,500
+116,234
| +236% | +$4.43M |
|
1347
Accuray
ARAY
$33.1M
| $6.44M | 0.01% |
3,081,020
-651,155
| -17% | -$1.35M |
|
1348
DigitalOcean
DOCN
$15.2B
| $6.43M | 0.01% |
252,500
-206,400
| -45% | -$6.46M |
|
1349
Lamar Advertising Co
LAMR
$15.9B
| $6.42M | 0.01% |
68,012
+35,400
| +109% | +$3.28M |
|
1350
Genie Energy
GNE
$384M
| $6.41M | 0.01% |
620,285
-15,400
| -2% | -$150K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.